• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VanEck Pharmaceutical ETF (NQ:PPH)

102.32 +0.47 (+0.46%)
Official Closing Price Updated: 4:15 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 163,004
Open 102.35
Bid (Size) 101.47 (3,000)
Ask (Size) 103.16 (2,900)
Prev. Close 101.85
Today's Range 102.20 - 103.14
52wk Range 81.74 - 112.58
Shares Outstanding N/A
Dividend Yield 1.22%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock ↗
March 10, 2026
BMO Capital maintained its ‘Market Perform’ rating for Novo Nordisk, with a price target of $45, implying an upside of more than 13% from NVO stock’s closing price on Monday. 
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy ↗
March 09, 2026
Hims & Hers also stated that it will no longer advertise compounded GLP-1 offerings on its platform or in its marketing. 
Via Stocktwits
Topics Intellectual Property Lawsuit

Performance

YTD
-1.4%
-1.4%
1 Month
-2.2%
-2.2%
3 Month
-4.2%
-4.2%
6 Month
+10.6%
+10.6%
1 Year
+17.4%
+17.4%

More News

Read More
News headline image
FDA Vaccine Chief Vinay Prasad To Exit Agency In April: Report ↗
March 06, 2026
Via Stocktwits
News headline image
Novo, Vivtex Ink $2.1 Billion Deal To Develop Oral Medicines For Obesity And Diabetes ↗
February 25, 2026
Via Stocktwits
Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report ↗
February 12, 2026
Via Stocktwits
KZIA Stock Is Rising Today — What Does Its Data For Nuclear PD-L1 Degrader Show? ↗
January 30, 2026
Via Stocktwits
Why Did NRXP Stock Surge 21% Pre-Market Today? ↗
January 14, 2026
Via Stocktwits
News headline image
Why Did GERN Stock Tumble 10% Pre-Market Today? ↗
February 25, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%: Report ↗
February 24, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
NVO Stock Continues To Decline Pre-Market After Monday’s Crash Amid CagriSema Setback – But Tuesday Brings Some Hope From China ↗
February 24, 2026
Via Stocktwits
News headline image
Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry ↗
February 23, 2026
Via Stocktwits
Topics Intellectual Property
News headline image
Why Is NVO Stock Falling Pre-Market Today? ↗
February 23, 2026
Via Stocktwits
Topics Government
News headline image
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains ↗
February 09, 2026
Via Stocktwits
Topics Lawsuit
News headline image
Why Did IINN Stock Surge 28% In Pre-Market Today? ↗
February 09, 2026
Via Stocktwits
News headline image
Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks ↗
February 09, 2026
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report ↗
December 01, 2025
Via Stocktwits
Topics World Trade
News headline image
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗
November 17, 2025
Via Benzinga
Topics ETFs
News headline image
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs ↗
November 15, 2025
Via Benzinga
Topics ETFs
News headline image
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗
November 12, 2025
Via Benzinga
News headline image
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗
October 30, 2025
Via Benzinga
Topics ETFs
News headline image
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet ↗
October 17, 2025
Via Benzinga
Topics ETFs Government
News headline image
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? ↗
October 13, 2025
Via The Motley Fool
Topics ETFs Government World Trade
News headline image
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
September 29, 2025
Via Benzinga
Topics ETFs
News headline image
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗
September 29, 2025
Via Benzinga
Topics Government World Trade
News headline image
Pharma Tariffs Back In Spotlight On New Trump Threat ↗
September 26, 2025
Via Investor's Business Daily
Topics ETFs Government World Trade

Frequently Asked Questions

Is VanEck Pharmaceutical ETF publicly traded?
Yes, VanEck Pharmaceutical ETF is publicly traded.
What exchange does VanEck Pharmaceutical ETF trade on?
VanEck Pharmaceutical ETF trades on the Nasdaq Stock Market
What is the ticker symbol for VanEck Pharmaceutical ETF?
The ticker symbol for VanEck Pharmaceutical ETF is PPH on the Nasdaq Stock Market
What is the current price of VanEck Pharmaceutical ETF?
The current price of VanEck Pharmaceutical ETF is 102.32
When was VanEck Pharmaceutical ETF last traded?
The last trade of VanEck Pharmaceutical ETF was at 05/01/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap